AAM Condemns ‘Build Back Better 2.0’ Due To Off-Patent Impact

US Draft Drug Legislation Could Complicate Market Entry For Generics And Biosimilars

 
• By Chloe Kent
  
Senator Joe Manchin is confronted by climate activists leaving his boat on his way to Capitol Hill
Build Back Better crumbled last year after Joe Manchin refused to vote for the legislation • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Policy & Regulation

More from Generics Bulletin